Sign in

CIK 0001516551

  • Non-accelerated filer
  • Smaller reporting company

Skye Bioscience, Inc.

Sign in to watch
Ticker
SKYE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
450692882
Phone
+1 858-410-0266
Business address
11250 EL CAMINO REAL, SUITE 100, SAN DIEGO, CA, 92130
Former names
Emerald Bioscience, Inc., Nemus Bioscience, Inc., LOAD GUARD LOGISTICS, INC., LOAD GUARD TRANSPORTATION, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$613,506
in 6 filings

Net −$613,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-12-14 Arsenault Kaitlyn Melanie Chief Financial Officer Grant or award · Stock Option (Right to Buy) +1,770,000 1,770,000
2021-12-14 Ward Keith Wayne Director Grant or award · Director Option Grant (Right to Buy) +250,000 250,000
2021-10-04 Arsenault Kaitlyn Melanie Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +1,600,000 2,000,000
2021-09-14 DALESANDRO MARGARET Director Grant or award · Director Stock Option (Right to Buy) +150,000 400,000
2021-09-14 HEPPELL JAMES L Director Grant or award · Director Stock Option (Right to Buy) +150,000 1,350,000
2021-09-14 TYLE PRAVEEN Director Grant or award · Director Stock Option (Right to Buy) +25,000 275,000
2021-07-22 TYLE PRAVEEN Director Grant or award · Director Option Grant (Right to Buy) +250,000 250,000
2020-08-07 Emerald Health Sciences Inc. 10% owner Sale −2,566,666 $0.10 $257K 123,923,501
2020-08-07 DALESANDRO MARGARET Director Grant or award · Director Option Grant (Right to Buy) +250,000 250,000
2020-08-07 Emerald Health Sciences Inc. 10% owner Sale −3,000,000 $0.10 $300K 123,490,167
2020-08-07 DHILLON PUNIT CEO Purchase +1,000,000 $100,000.00 $100.0B 1,000,000
2020-08-07 DHILLON PUNIT CEO Grant or award · Employee Option Grant (Right to Buy) +9,000,000 9,200,000
2020-08-07 HEPPELL JAMES L Director Purchase +500,000 $50,000.00 $25.0B 500,000
2020-08-07 HEPPELL JAMES L Director Grant or award · Director Option Grant (Right to Buy) +1,000,000 1,200,000
2020-08-07 KIM DENNIS D Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +4,000,000 4,736,541
2020-08-07 Traistaru Elena CFO and Secretary Grant or award · Consultant Option Grant (Right to Buy) +1,000,000 1,000,000
2019-12-20 Emerald Health Sciences Inc. 10% owner Other acquisition +40,800,000 $4,080,000.00 $166464.0B 126,490,167
2019-12-20 Emerald Health Sciences Inc. 10% owner Other disposition · Warrant(Right to Buy) −40,800,000 $0.10 $4.1M 0
2019-12-20 Emerald Health Sciences Inc. 10% owner Other disposition · 7% Convertible Debt −4,080,000 $0.40 $1.6M 5,036,250
2019-08-21 KIM DENNIS D Chief Medical Officer Grant or award · Employee Stock Options (Right to Buy) +736,541 736,541

Page 12 of 15 · 292 trades